<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="inflammatory component (arthritis/tenosynovitis), corticosteroid use after 14 days is effective." exact="Prednisone" post="0.5 milligram per kilogram per day (maximum dose being"/>
 <result pre="use. In older patients, amitriptyline may lead to sedation, therefore," exact="gabapentin" post="is often preferred starting at low doses. Patients with"/>
 <result pre="Patients with a history of arrhythmia should also be administered" exact="gabapentin" post="instead of amitriptyline. Approximately 30% of CHIKV patients may"/>
 <result pre="The drugs of choice at this stage are antimalarials, preferably" exact="hydroxychloroquine" post="(HCQ). In this guideline, methotrexate (MTX) is an option"/>
 <result pre="this stage are antimalarials, preferably hydroxychloroquine (HCQ). In this guideline," exact="methotrexate" post="(MTX) is an option for inflammatory joint disease (moderate"/>
 <result pre="reviewArthritis Care ResHoboken2018701015011508 22DeLamballerie XBoissonVReynierJ-CEnaultSCharrelRNFlahaultAet al.On Chikungunya Acute Infection and" exact="Chloroquine" post="TreatmentVector-Borne Zoonotic Dis20088683784018620511 23PandyaSMethotrexate and hydroxychloroquine combination therapy in"/>
 <result pre="Chikungunya Acute Infection and Chloroquine TreatmentVector-Borne Zoonotic Dis20088683784018620511 23PandyaSMethotrexate and" exact="hydroxychloroquine" post="combination therapy in chronic chikungunya arthritis: A 16 week"/>
 <result pre="parallel-group studyIndian J Rheumatol2009439410110.1016/S0973-3698(10)60189-6 25RavindranVAliasGEfficacy of combination DMARD therapy vs." exact="hydroxychloroquine" post="monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized"/>
</results>
